Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹81 Cr
Revenue (TTM)
₹33 Cr
Net Profit (TTM)
₹1 Cr
ROE
4 %
ROCE
5 %
P/E Ratio
145.3
P/B Ratio
4.3
Industry P/E
40.56
EV/EBITDA
70.5
Div. Yield
0 %
Debt to Equity
0
Book Value
₹11.5
EPS
₹0.3
Face value
10
Shares outstanding
16,273,800
CFO
₹6.64 Cr
EBITDA
₹12.92 Cr
Net Profit
₹8.53 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
| -12.7 | 14.6 | 13.4 | -18.7 | -3.2 | 31.0 | -- |
|
BSE Healthcare
| -2.6 | 5.8 | 11.7 | 19.7 | 25.9 | 22.2 | 11.0 |
|
BSE Small Cap
| -2.6 | 9.6 | 21.0 | 6.2 | 27.3 | 35.1 | 17.6 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
| 6.4 | -1.9 | -11.5 | -65.9 | 789.3 | 196.4 | -60.9 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
|
50.1 | 81.0 | 33.4 | 0.6 | 1.4 | 3 | 145.3 | 4.3 |
| 885.7 | 8,026.2 | 2,115.1 | 272.4 | 17.8 | 14.2 | 29.5 | 4.0 | |
| 1,104.7 | 9,039.6 | 1,006.9 | 160.4 | 20.4 | 12.6 | 57 | 6.9 | |
| 572.3 | 8,990.3 | 4,118.2 | 343.8 | 7.6 | 10.7 | 26.6 | 2.9 | |
| 375.8 | 4,634.9 | 1,859.8 | 90.8 | 10.4 | 7.4 | 51 | 3.7 | |
| 907.3 | 5,202.3 | 1,243.7 | 128.3 | 13.0 | 13.8 | 40.6 | 5.4 | |
| 1,007.8 | 2,488.2 | 356.3 | 100.9 | 25.0 | 13.3 | 24.7 | 3.2 | |
| 58.4 | 2,232.7 | 488.2 | 70.5 | 17.2 | 13 | 32.1 | 3.7 | |
| 165.9 | 5,383.8 | 71.8 | -342.5 | -467.5 | -- | -- | -24.8 | |
| 963.5 | 2,867.9 | 293.0 | -56.7 | -16.7 | -29.5 | -- | 9.2 |
No Review & Analysis are available.
Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride,... sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India. Read more
Incorporated
1985
Chairman
--
Managing Director
--
Headquarters
Indore, Madhya Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Biofil Chemicals & Pharmaceuticals Ltd stood at ₹ 51 Cr as on 31-Mar-25
The share price of Biofil Chemicals & Pharmaceuticals Ltd is ₹50.14 (NSE) and ₹49.74 (BSE) as of 13-Jun-2025 IST. Biofil Chemicals & Pharmaceuticals Ltd has given a return of -3.21% in the last 3 years.
Biofil Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹ 81 Cr as on 13-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Biofil Chemicals & Pharmaceuticals Ltd is 4.31 times as on 13-Jun-2025, a 14% premium to its peers’ median range of 3.78 times.
The P/E ratio of Biofil Chemicals & Pharmaceuticals Ltd is 145.32 times as on 13-Jun-2025, a 258% premium to its peers’ median range of 40.56 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Biofil Chemicals & Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Biofil Chemicals & Pharmaceuticals Ltd.
Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.
The prominent promoters of Biofil Chemicals & Pharmaceuticals Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
SCOPE FINANCE COMPANY PRIVATE LIMITED |
13.9%
|
|
MID (INDIA) PHARMACEUTICALS PVT LTD |
7.22%
|
|
CYANO FINANCE AND SALES PVT. LTD. |
5.39%
|
|
MEENA SHAH |
3.86%
|
The chairman of the company is , and the managing director is .
There is no promoter pledging in Biofil Chemicals & Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,040
|
|
|
8,990
|
|
|
8,026
|
|
|
5,384
|
|
|
5,202
|
|
|
4,635
|
|
|
2,868
|
|
|
2,488
|
|
|
2,233
|
| Biofil Chemicals & Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
3
|
|
Operating margin(%)
|
1.4
|
|
Net Margin(%)
|
1.65
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Biofil Chemicals & Pharmaceuticals Ltd was ₹1 Cr.
₹-1.76
(
